Navigation Links
Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
Date:11/6/2008

SOUTH SAN FRANCISCO, Calif., Nov. 6 /PRNewswire/ -- Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular and inflammatory diseases, and cancer, today announced that data relevant to betrixaban, the company's novel oral Factor Xa inhibitor and PRT060128, its novel ADP receptor antagonist, will be presented at the American Heart Association (AHA) Scientific Sessions 2008. The conference will be held at the Ernest N. Morial Convention Center in New Orleans, LA during November 8-12, 2008.

"We have important data being presented at AHA that demonstrate the potential of our differentiated Phase II compounds that address major unmet needs in preventing and treating thrombosis," said Charles Homcy, M.D., president and chief executive officer of Portola. "In particular, data from Dr. Paul Gurbel show how our antiplatelet agent may be effective in a high percentage of patients who do not respond adequately to clopidogrel, the current standard of care. Additionally, data being presented will show that our two Phase II agents, PRT060128 and betrixaban, our oral once-daily FXa inhibitor, may work in combination to inhibit thrombosis without raising bleeding risk. Together these data highlight some of the unique properties of our lead antithrombotic compounds."

Following are the details on each poster presentation.

Monday, November 10

Poster Title: "Combination of Direct Acting FXa Inhibitor and P2Y12

Antagonist at Non-Effective Doses Provides Significant Inhibition of

Arterial Thrombosis"

Patrick Andre et al

Time: 9:00 a.m. - 5:00 p.m.

Hall A-B1, Poster Board B129

Wednesday, November 12

Poster Title: "Oral Dosing of PRT060128, a Novel Direct-acting,

Reversible P2Y12 Antagonist Overcomes High Platelet Reactivity in

Patients Non-responsive to Clopidogrel Therapy"

Paul A. Gurbel et al

'/>"/>
SOURCE Portola Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
2. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
3. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
4. NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
5. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
6. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
7. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
10. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
11. Lutonix Inc. Announces $20 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 4, 2015 Sanomedics , ... a medical technology company that focuses on providing ... that the Company,s subsidiary, Thermomedics, Inc. , has ... and Government Sales. LeBel will be reporting to ... Sales, and will be responsible for supporting assigned ...
(Date:3/4/2015)... DIEGO , March 4, 2015  Imprimis Pharmaceuticals, ... focused on the development and commercialization of proprietary compounded ... fourth quarter and fiscal year 2014 financial results on ... conference call at 4:30 p.m. EDT (1:30 p.m. PDT) ... and report on recent business activities.  The conference call ...
(Date:3/4/2015)... DUBLIN , March 4, 2015   Mallinckrodt ... specialty biopharmaceutical company, will present at the Barclays Global ... Miami, Florida , on Wednesday, March 11, ... will represent the company in a session scheduled to ... cannot attend the meeting in person can find webcast ...
Breaking Medicine Technology:Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 2Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 3Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3Mallinckrodt to Present at Barclays Conference March 11 2
... Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) ... that Pharma Tech International (PTI), a joint venture of ... $500,000 minimum sales agreement with Cure Hands, a company ... In the agreement, Pharma Tech International, the exclusive distributor ...
... A poster entitled, "Time to Progression in ... versus Degarelix Following Leuprolide Treatment," is being presented ... David Crawford, MD, head of the Section of Urologic ... in Denver, and lead study investigator. The full manuscript ...
Cached Medicine Technology:International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 2International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 3International Sales Agreement Signed by WNDM Subsidiary; $500K First-Year Sales Commitment 4Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 2Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 3Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 4Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide 5
(Date:3/4/2015)... (PRWEB) March 04, 2015 Cook For ... organization that teaches healthy cooking to people touched by ... Hope Lodge. The program, run by founder Ann Ogden, ... and Sport Management. The unique partnership will expand the ... Ogden founded CFYL in 2007. After going through her ...
(Date:3/4/2015)... Blake’s All Natural Foods , a leader ... year’s Natural Products Expo West in Anaheim, California, showcasing ... line, Blake’s, who has the top four selling frozen ... to creating high-quality dishes that are easily prepared. , ... channel, Blake’s understands what educated consumers are looking for ...
(Date:3/4/2015)... 2015 Alliance Healthcare Foundation (AHF), a ... those in need in San Diego and Imperial Counties, ... its Mission Support Grants program with awards totaling $1 ... for AHF’s Mission Support Grants program. Grant recipients were ... trustees and program committee, as well as the community ...
(Date:3/4/2015)... Texas (PRWEB) March 04, 2015 ... , Endometriosis can be a painful condition ... starts spreading outside of the uterus leading to very ... their families. Endometriosis can have a terrible effect on ... It is also the most common cause of infertility ...
(Date:3/4/2015)... La Farge, Wis. (PRWEB) March 04, 2015 ... a leading organic brand, today announced its cause campaign to ... has gone viral and is making a difference to Bros ... million views on Youtube and Facebook. The video was ... and was featured in Forbes, Mashable and Digiday, among other ...
Breaking Medicine News(10 mins):Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 2Health News:Fastest Growing Frozen Brand in Natural Channel Showcases New Line at Expo West 2015 3Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3
... still looking for a date for Valentine,s Day? Here,s some dating ... something to "playing hard to get." A study published in ... finds that a woman is more attracted to a man when ... On the one hand, a lot of psychological research has found ...
... million, five-year grant from the National Cancer Institute will ... called Latinos Contra El Cancer, to reduce cancer-related health ... a joint project of The University of Texas Health ... and The University of Texas MD Anderson Cancer Center. ...
... 7, 2011 Geneva, Switzerland. Following the publication of ... fraud discovered in grants financed by the Global Fund ... Society (IAS) urges all donors and governments to continue ... and innovative financing instrument which attracts, manages and disburses ...
... A digital signal processing technique long used by statisticians ... roots of memory and learning, Alzheimer,s and Parkinson,s diseases ... University of Texas Health Science Center at Houston (UTHealth) ... that single molecule fluorescence resonance energy transfer (FRET) ...
... works, an anthropologist tackles a perplexing question relating to the ... and even celebrate the public display of human corpses? ... Human Bodies " is the most widely attended exhibit in ... anthropology at the University of Illinois and author of a ...
... , MONDAY, Feb. 7 (HealthDay News) -- Living ... health risks such as smoking or obesity, researchers have ... families, Cornell University researchers asked 17-year-olds and their mothers ... measure of how connected their community is and the ...
Cached Medicine News:Health News:'He loves me, he loves me not...': Women are more attracted to men whose feelings are unclear 2Health News:Project connects researchers, Latino communities to prevent cancer 2Health News:Project connects researchers, Latino communities to prevent cancer 3Health News:Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS 2Health News:Researchers get a grip on nervous system's receptors 2Health News:Researchers get a grip on nervous system's receptors 3Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 2Health News:Anthropologist: 'Body Worlds' visitors confront bodies but not death 3Health News:Community Has a Role in Health of Low-Income Kids 2
The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
SPR treats pigmented and vascular lesions, skin aging, sun damaged skin and fine lines and wrinkles with clinically proven LHE technology....
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
Medicine Products: